73 unknown. 73 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 73 | Unknown 73 |
Follow Bronchial Diseases: new trials by email Literature Review of Bronchial Diseases trials Research Report on Bronchial Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunologic Impact of Dupilumab in Patients Suffering From Asthma and Chronic Rhinosinusitis With Polyps Dupilumab, Placebo - Chronic Rhinosinusitis With Nasal Polyps, Asthma | Phase 4 | Unknown | Dr. Andrew Thamboo, MD | 60 | 2024-08-01 | 2024-08-16 |
| Effect of the Inhaled Triple Therapies Over the Small Airway in Biomass Exposure Vilanterol / Umeclidinium (25/62.5 mcg), Fluthicasone / Vilanterol / Umeclidinium (100/25/62.5 mcg), Beclomethasone / Formoterol / Glycopyrronyum 100/6/12.5 mcg - COPD Bronchitis, Pollution Related Respiratory Disorder | Phase 4 | Unknown | National Institute of Respiratory Diseases, Mexico | 128 | 2023-11-15 | 2024-08-26 |
| Ceftolozane/Tazobactam Continuous Infusion for Infective Exacerbations of Cystic Fibrosis and Bronchiectasis Ceftolozane/tazobactam - Bronchiectasis, Cystic Fibrosis | Phase 4 | Unknown | Sunshine Coast Hospital and Health Service | 30 | 2023-10-01 | 2023-09-13 |
| Comparison of Immune Profiles in Chronic Rhinosinusitis Patients After Mepolizumab Treatment Mepolizumab, Placebo - Chronic Rhinosinusitis With Nasal Polyps, Asthma | Phase 4 | Unknown | St. Paul's Sinus Centre | 90 | 2023-07-01 | 2024-04-17 |
| Azithromycin Treatment for Non-eosinophilic Chest Tightness Variant Asthma Azithromycin, ICS/LABA - Asthma, Chest Syndrome | Phase 4 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 248 | 2023-01-01 | 2022-11-04 |
| Immunogenicity and Safety of a Third Dose and Immune Persistence of BBIBP-Corv Vaccine in Elderly People With Chronic Bronchitis and COPD Inactivated COVID-19 vaccine - COVID-19, Chronic Bronchitis | Phase 4 | Unknown | China National Biotec Group Company Limited | 400 | 2021-12-01 | 2021-11-02 |
| Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in Patients Aged ≥60 Years With Chronic Bronchitis and COPD Inactivated COVID-19 vaccine - COVID-19, Chronic Bronchitis | Phase 4 | Unknown | China National Biotec Group Company Limited | 400 | 2021-10-08 | 2021-10-22 |
| Immunogenicity and Safety of an Inactivated COVID-19 Vaccine in Elderly People With Chronic Bronchitis and COPD Inactivated COVID-19 vaccine - COVID-19, Chronic Bronchitis | Phase 4 | Unknown | China National Biotec Group Company Limited | 400 | 2021-10-08 | 2021-10-22 |
| Mechanisms of Adverse Effects of Long-Acting Beta-Agonists in Asthma Salmeterol Xinafoate, Salmeterol Fluticasone - Asthma | Phase 4 | Unknown | Imperial College London | 24 | 2021-07-23 | 2023-04-25 |
| Effect of Zhuli Capsule on Phlegm-heat Syndrome (Tan-re Zheng) Zhuli capsule, Placebo, Standard medical treatment - Chronic Obstructive Pulmonary Disease, Chronic Bronchitis | Phase 4 | Unknown | Zhong Wang | 324 | 2021-07-01 | 2021-06-15 |
| Flow Cytometry Analysis of Eosinophils in Severe Asthma Patients. anti IL5 receptor antibodies - Severe Asthma | Phase 4 | Unknown | Scarlata, Simone, M.D. | 80 | 2021-03-18 | 2021-08-12 |
| Effect of Dupilumab on Aspirin Intolerance Dupilumab - AERD - Aspirin Exacerbated Respiratory Disease | Phase 4 | Unknown | Medical University of Vienna | 30 | 2020-06-01 | 2022-04-06 |
| The Efficacy of Budesonide/Formoterol in Cough Variant Asthma budesonide/formoterol - Cough Variant Asthma | Phase 4 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 500 | 2020-05-01 | 2020-05-12 |
| Anti-viral Effects of Azithromycin in Patients With Asthma and COPD Azithromycin, Placebo oral tablet - Asthma, COPD | Phase 4 | Unknown | Bispebjerg Hospital | 100 | 2020-03-02 | 2021-07-26 |
| Study on the Correlation Between Intestinal Microecology and Allergic Diseases in Children probiotics, conventional medical treatment - Rhinitis, Allergic, Asthma | Phase 4 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 200 | 2020-03-01 | 2021-06-24 |
| A Pragmatic Study to Investigate the Efficacy and Safety of Mepolizumab in Severe Uncontrolled Asthma in Brazil Mepolizumab 100 MG [Nucala] - Eosinophilic Asthma | Phase 4 | Unknown | University of Sao Paulo General Hospital | 18 | 2020-01-09 | 2020-01-14 |
| Comparison Efficacy in Patients With Asthma Using Foster MDI and Relvar Medications Foster - Asthma | Phase 4 | Unknown | Far Eastern Memorial Hospital | 200 | 2020-01-01 | 2019-12-04 |
| A Series of N-of-1 Trials of Traditional Chinese Medicine Based on Bayesian Method Individualized Decoction, placebo, Tested drug minus heat-clearing herbs - Bronchiectasis, Quality of Life | Phase 4 | Unknown | Shanghai University of Traditional Chinese Medicine | 71 | 2019-12-01 | 2020-10-26 |
| Study of Magnitude and Prediction of Response to Omalizumab and Mepolizumab in Adult Severe Asthma. Randomisation to omalizumab, Randomisation to mepolizumab - Severe Asthma | Phase 4 | Unknown | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 100 | 2019-05-10 | 2022-10-27 |
| Effectiveness of Tricortin 1000 in Patients Affected by Chronic Low Back Pain Tricortin 1000, Itami, Placebo - Low Back Pain, Mechanical | Phase 4 | Unknown | Fidia Farmaceutici s.p.a. | 300 | 2019-03-25 | 2023-10-27 |
Showing 20 of 73. Sign in to see all of them.
Asthma (42) · Pulmonary Disease, Chronic Obstructive (12) · Bronchiectasis (8) · Bronchitis, Chronic (8) · Cough-Variant Asthma (6) · Bronchiolitis (3) · Bronchiolitis Obliterans Syndrome (3) · Bronchitis (3) · COVID-19 (3) · Pulmonary Eosinophilia (3) · Emphysema (2) · Pneumonia (2) · Rhinitis, Allergic (2) · Asthma, Occupational (1) · Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome (1)
Respiratory Tract Diseases (73) · Lung Diseases (65) · Lung Diseases, Obstructive (63) · Immune System Diseases (50) · Hypersensitivity (47) · Respiratory Hypersensitivity (47) · Hypersensitivity, Immediate (46) · Infections (17) · Pathological Conditions, Signs and Symptoms (17) · Pathologic Processes (15) · Respiratory Tract Infections (15) · Bronchitis (14) · Disease Attributes (13) · Chronic Disease (12)
Budesonide (6) · Budesonide, Formoterol Fumarate Drug Combination (6) · Formoterol Fumarate (6) · Omalizumab (3) · Salmeterol Xinafoate (3) · mepolizumab (3) · Albuterol (2) · Azithromycin (2) · Beclomethasone (2) · Cholecalciferol (2) · Methacholine Chloride (2) · Sodium Chloride (2) · dupilumab (2) · Adenosine Monophosphate (1) · Anti-Asthmatic Agents (1)
Bispebjerg Hospital (4) · Medical University of Lodz (4) · Zhujiang Hospital (4) · China National Biotec Group Company Limited (3) · Second Affiliated Hospital, Zhejiang University, School of Medicine (3) · Shanghai Pulmonary Hospital, Shanghai, China (3) · The First Affiliated Hospital of Guangzhou Medical University (3) · Jiangxi Qingfeng Pharmaceutical Co. Ltd. (2) · National Institute of Respiratory Diseases, Mexico (2) · Shanghai University of Traditional Chinese Medicine (2) · All India Institute of Medical Sciences (1) · Allergy and Asthma Center of El Paso (1) · Asan Medical Center (1) · Aveiro-Aradas Family Health Unit (1) · California Allergy and Asthma Medical Group, Inc. (1)
China (22) · United States (8) · Denmark (4) · Poland (4) · Brazil (3) · Canada (3) · Italy (3) · Mexico (3) · Spain (3) · South Korea (2) · Australia (1) · Austria (1) · Belgium (1) · India (1) · Israel (1)
Iwona Stelmach, MD, PhD, Prof (3) · Jimmi Elers, MD (3) · Hanqing He (2) · Albrecht Breitenbuecher, MD (1) · Ana Luisa G Fernandes, MD, PhD (1) · Andrew Burke, MBBS (1) · Andrew Thamboo (1) · Barbara P Yawn, MD MSc (1) · Benedicto Crespo Facorro, MDPhD (1) · Benjamin D. Gold, MD. (1) · Bingyi Wu, MD (1) · Celeste Porsbjerg, MD, PhD (1)
PMID 11113831, PMID 11825832, PMID 18331513, PMID 20887423, PMID 21060320, PMID 21398686, PMID 21697993, PMID 21782228, PMID 22153774, PMID 22394648, PMID 23076388, PMID 23101012, PMID 23371406, PMID 23758233, PMID 24232697, PMID 24671923, PMID 24809759, PMID 24872685, PMID 24952426, PMID 25419479, PMID 25477988, PMID 26321593, PMID 26508124, PMID 28284475, PMID 28592289, PMID 29531100, PMID 29552084, PMID 29889987, PMID 30696670, PMID 31594030, PMID 34122611, PMID 34744427, PMID 35087595, PMID 36217131, PMID 41309110
2019 (2), 2005 (1), 2017 (1)